A good bit of holiday news is the new finding that the rapid increase in COVID-19 infections in South Africa with the Omicron variant has begun to decline. As quickly as the infections rose, they appear to be decreasing just as fast.

While this does not rule out a second peak, several things are clear. There is much more background immunity in the population due to the prior waves of COVID infection and vaccination. This likely reduces the number of people who are susceptible to Omicron infection. Therefore, while this highly infectious variant burned through the susceptible population very quickly, since there weren’t nearly as many individuals that could be infected, the wave ended sooner.
Another result of prior immunity (and maybe the virus itself) is an increase in asymptomatic or mild infections. These people would not have been identified since they would not have been tested, so that the peak was actually earlier and number of infectious individuals was greater than thought, leading to a decline sooner than expected.
Reinforcing the mild nature of Omicron infection is the fact that despite large numbers of individuals being infected, hospitalizations, serious illness, and deaths were proportionally less common with this wave.

What does this mean for the United States?
Potentially the Omicron wave will burn rapidly through the population but cause less disruption, serious illness, and death. But there are several caveats to this hopeful thought.
First, The U.S. population is larger and uses more per capita healthcare resources than South Africa. As the U.S. gets more aggressive with testing, we may also identify more infections that are mild, but use healthcare resources. Thus, the impact on the U.S. health care system may still be substantial.
Importantly, even though we have been through several waves of COVID-19 infection, there are large numbers of unvaccinated and unexposed individuals. Therefore, the number of individuals susceptible to infection with Omicron may be greater in the U.S. than in South Africa.
Therefore, while this news is truly a hopeful sign for the U.S., during this holiday season we need to stay vigilant!
Hi Jim! You should write about the syringe and needle shortage.., that is a big deal. https://www.reuters.com/business/healthcare-pharmaceuticals/who-warns-shortage-1-2-bln-covid-vaccine-syringes-2021-11-09/
Happy Holidays!
Gus
LikeLiked by 1 person
Agree. A major issue.
LikeLike
Might this trend also be evidence that we’re finally reaching the “herd immunity” goal that was being discussed a year and a half ago?
LikeLiked by 1 person
Maybe in South Africa!
LikeLike
Best news we’ve heard recently on the pandemic. After a lengthy surge from Delta overwhelming hospitals with very sick people, if would be nice if Omicron was milder and helped further the herd immunity.
LikeLiked by 1 person
Should we get a 4th shot? Israel is recommending this due to Omicron. I would love your advice on this. Its been over 3 months since my boost (Pfizer).
LikeLike
Way too early to decide, especially simply based on test tube neutralization tests. One concern, too many vaccinations in too short a time can actually suppress immunity. So this decision needs to be carefully evaluated.
LikeLike